COMBINED MODALITY TREATMENT USING RADIATION AND OR CHEMOTHERAPY IN AN ATHYMIC (NUDE) MOUSE-HUMAN MEDULLOBLASTOMA AND GLIOBLASTOMA XENOGRAFT MODEL

被引：0
|
作者：
SLAGEL, DE
FEOLA, J
HOUCHENS, DP
OVEJERA, AA
机构：
[1] UNIV KENTUCKY,COLL MED,DEPT SURG & RADIAT THERAPY,LEXINGTON,KY 40506
[2] BATTELLE MEM INST,COLUMBUS LABS,COLUMBUS,OH 43201
来源：
EXPERIMENTAL CELL BIOLOGY | 1982年 / 50卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：347 / 347
页数：1
相关论文
共 36 条
  • [31] Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy
    Christopher M. McPherson
    Margie Gerena-Lewis
    John C. Breneman
    Ronald E. Warnick
    Journal of Neuro-Oncology, 2012, 108 : 521 - 525
  • [32] Dynamic contrast-enhanced ultrasonographic (DCE-US) assessment of the early response after combined gemcitabine and HIFU with low-power treatment for the mouse xenograft model of human pancreatic cancer
    Kim, Jung Hoon
    Kim, Haeri
    Kim, Young Jae
    Lee, Jae Young
    Han, Joon Koo
    Choi, Byung-Ihn
    EUROPEAN RADIOLOGY, 2014, 24 (09) : 2059 - 2068
  • [33] 111In-Cetuximab-F(ab′)2 SPECT and 18F-FDG PET for Prediction and Response Monitoring of Combined-Modality Treatment of Human Head and Neck Carcinomas in a Mouse Model
    van Dijk, Laura K.
    Boerman, Otto C.
    Franssen, Gerben M.
    Kaanders, Johannes H. A. M.
    Bussink, Johan
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (02) : 287 - 292
  • [34] COMBINED MODALITY TREATMENT OF OPERATED ASTROCYTOMAS GRADE-3 AND GRADE-4 - A PROSPECTIVE AND RANDOMIZED STUDY OF MISONIDAZOLE AND RADIOTHERAPY WITH 2 DIFFERENT RADIATION SCHEDULES AND SUBSEQUENT CCNU CHEMOTHERAPY - STAGE-II OF A PROSPECTIVE MULTICENTER TRIAL OF THE SCANDINAVIAN GLIOBLASTOMA STUDY-GROUPD
    HATLEVOLL, R
    LINDEGAARD, KF
    HAGEN, S
    KRISTIANSEN, K
    NESBAKKEN, R
    TORVIK, A
    GANZ, JC
    MELLA, O
    ROSENGREN, B
    RINGKJOB, R
    ARNASSON, O
    LINDGREN, S
    LIPECKI, M
    NOTTER, G
    LITTBRAND, B
    SATERBORG, NE
    BENEDIKTSSON, G
    JOHANSSON, L
    SPANNARE, B
    BRUN, A
    BERTHELSEN, A
    BUSCH, H
    GRONBAEK, E
    RYGARD, J
    HAASE, JP
    LAMBRETHSEN, E
    MIDHOLM, S
    SEHESTED, P
    HEIKKINEN, M
    NYSTROM, S
    TASKINEN, P
    MANTYLA, M
    ELGEN, K
    AASKOVEN, O
    DEGARIS, ST
    JENSEN, RH
    MATHESON, I
    CANCER, 1985, 56 (01) : 41 - 47
  • [35] Anti-CD45 Ab Pretargeted Radioimmunotherapy Using An Alpha Emitting Radionuclide (213Bi) Delivers Selective Radiation to Human Myeloid Leukemias in a Mouse Xenograft Model and Results in High Rates of Complete Remission and Long Term Survival.
    Kenoyer, Aimee L.
    Press, Oliver W.
    Park, Steven I.
    Back, Tom
    Hamlin, Donald K.
    Wilbur, D. Scott
    Fisher, Darrell R.
    Wilbur, Shani M.
    Axtman, Amanda
    Orgun, Nural
    Lin, Yukang
    Gopal, Ajay K.
    Shenoi, Jaideep
    Green, Damian J.
    Appelbaum, Frederick R.
    Pagel, John M.
    BLOOD, 2009, 114 (22) : 428 - 428
  • [36] Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer
    Sugyo, Aya
    Tsuji, Atsushi B.
    Sudo, Hitomi
    Koizumi, Mitsuru
    Ukai, Yoshinori
    Kurosawa, Gene
    Kurosawa, Yoshikazu
    Saga, Tsuneo
    Higashi, Tatsuya
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
1234